PTHS
PTHS
US1711262048
Pelthos Therapeutics Inc.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 16.795.000 --
--
Cost of Revenue 9.365.000 --
--
Gross Profit 7.430.000 --
--
39.860.000 7.571.000
426.5%
Operating Income -32.430.000 -7.571.000
328.3%
Pretax Income -50.706.000 -7.955.000
537.4%
Net Income Common Stockholders -43.319.000 -7.955.000
444.6%
-- --
--
-- --
--
ende